KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Total Liabilities (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Total Liabilities for 17 consecutive years, with $9.1 billion as the latest value for Q4 2025.

  • Quarterly Total Liabilities fell 3.05% to $9.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.1 billion through Dec 2025, down 3.05% year-over-year, with the annual reading at $9.1 billion for FY2025, 3.05% down from the prior year.
  • Total Liabilities hit $9.1 billion in Q4 2025 for Quest Diagnostics, up from $8.9 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $9.3 billion in Q4 2024 to a low of $6.7 billion in Q1 2023.
  • Historically, Total Liabilities has averaged $7.7 billion across 5 years, with a median of $7.1 billion in 2021.
  • Biggest five-year swings in Total Liabilities: decreased 7.24% in 2021 and later skyrocketed 31.84% in 2024.
  • Year by year, Total Liabilities stood at $7.1 billion in 2021, then fell by 3.1% to $6.9 billion in 2022, then grew by 11.19% to $7.7 billion in 2023, then grew by 21.61% to $9.3 billion in 2024, then decreased by 3.05% to $9.1 billion in 2025.
  • Business Quant data shows Total Liabilities for DGX at $9.1 billion in Q4 2025, $8.9 billion in Q3 2025, and $8.7 billion in Q2 2025.